Several analysts have recently updated their ratings and price targets for Kimberly-Clark (NASDAQ: KMB):
- 11/3/2025 – Kimberly-Clark was given a new $132.00 price target on by analysts at Barclays PLC.
- 10/31/2025 – Kimberly-Clark had its price target raised by analysts at JPMorgan Chase & Co. from $127.00 to $129.00. They now have a “neutral” rating on the stock.
- 10/31/2025 – Kimberly-Clark had its price target lowered by analysts at TD Cowen from $135.00 to $130.00. They now have a “hold” rating on the stock.
- 10/31/2025 – Kimberly-Clark had its price target raised by analysts at UBS Group AG from $130.00 to $132.00. They now have a “neutral” rating on the stock.
- 10/30/2025 – Kimberly-Clark is now covered by analysts at Weiss Ratings. They set a “hold (c+)” rating on the stock.
- 10/28/2025 – Kimberly-Clark had its “overweight” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $162.00 price target on the stock.
- 10/10/2025 – Kimberly-Clark had its price target lowered by analysts at JPMorgan Chase & Co. from $144.00 to $127.00. They now have a “neutral” rating on the stock.
- 10/9/2025 – Kimberly-Clark had its price target lowered by analysts at Citigroup Inc. from $118.00 to $113.00. They now have a “sell” rating on the stock.
- 10/8/2025 – Kimberly-Clark had its price target lowered by analysts at UBS Group AG from $140.00 to $130.00. They now have a “neutral” rating on the stock.
- 10/2/2025 – Kimberly-Clark had its price target lowered by analysts at Piper Sandler from $149.00 to $145.00. They now have an “overweight” rating on the stock.
- 10/1/2025 – Kimberly-Clark had its price target lowered by analysts at Barclays PLC from $139.00 to $131.00. They now have an “equal weight” rating on the stock.
- 9/25/2025 – Kimberly-Clark had its price target lowered by analysts at Wells Fargo & Company from $140.00 to $130.00. They now have an “equal weight” rating on the stock.
- 9/22/2025 – Kimberly-Clark had its price target lowered by analysts at Evercore ISI from $155.00 to $150.00. They now have an “outperform” rating on the stock.
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also
- Five stocks we like better than Kimberly-Clark
- The 3 Best Retail Stocks to Shop for in August
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- What is a Low P/E Ratio and What Does it Tell Investors?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Most Volatile Stocks, What Investors Need to Know
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Kimberly-Clark Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
